Abstract:The 3T3-Ll adipocyte differentiation system is a reliable in vitro model for adipogenesis in vivo. Under the controlled conditions of cell culture, 3T3-Ll preadipocytes can be induced (with appropri- ate hormonal agents) to differentiate into cells that have the biochemical and morphological characteris- tics of tissue adipocytes. We have identified, cloned, and characterized a number of adipocyte genes that are coordinately activated during differentiation and contribute to acquisition of the adipocyte phenotype. C/EBPa serves as a pleiotropic transcriptional activa- tor of these and many other adipocyte genes. Expres- sion of C/EBPa is not only required for, but is sufficient (in combination with PPARy) to activate the differentiation program of 3T3-Ll preadipocytes without the use of hormonal agents. In view of the importance of CEBPa in adipocyte differentiation, we have begun to characterize the promoter of the C/ EBPa gene. In addition to a C/EBP regulatory element in the proximal promoter of the gene, we have identified three repressor binding sites. A differen- tially expressed nuclear factor that binds to two of these sites has been isolated and characterized. This factor, referred to as CUP (C/EBPa Undifferentiated Protein), is expressed by preadipocytes but not adipocytes. Both the mouse and human C/EBPa genes possess two CUP binding sites, one in the 5'-flanking and another in the 5'-untranslated region of the genes. Mutation of either CUP site individually has little effect on reporter gene transcription medi- ated by the promoter; however, when both CUP sites are mutated marked synergistic "derepression" occurs. We have purified CUP from 3T3-Ll preadipocytes and shown it to be an isoform of the transcription factor AP-2a. Forced expression of the AP-2al isoform in adipocytes, which normally do not express this factor, inhibits reporter gene transcription mediated by the C/EBPa promoter. Our findings indicate that CUP/AP- 201 is a repressor of the C/EBPa gene promoter and suggest that this factor maintains the gene in a repressed state prior to differentiation. A binding site (a GC box) for another repressor has been identified at the 5'-end of the CEBP regulatory element in the C/EBPa promoter. The transcription factor Spl, which is expressed by preadipocytes, was found to bind at this site. By binding at this site, Spl sterically can block access to the C/EBP binding site by members of the CEBP family. Thus, transcriptional activation of the C/EBPa a gene by C/EBPP (and possibly C/EBPG) , which is thought to occur early in the adipocyte differentiation program, would be prevented. Consis- tent with this view, transactivation of C/EBPa promoter by C/EBPP is inhibited by Spl. Preliminary evidence indicates that the differentiation inducers increase the rate of turnover of Spl. Lowering the Spl level early in the differentiation program would facilitate binding of C/EBPP to the C/EBP regulatory element and, thereby, transcriptional activation of the C/EBPa gene. Adipocyte, 3T3-Ll Cells, C/EBPa, C/EBPP

Modulation of vitamin D signaling by the pioneer factor CEBPA

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Vitamin D3 and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells

Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines

In vivo vitamin D target genes interconnect key signaling pathways of innate immunity

C/EBP‐α, Involvement of a Novel Transcription Factor in Leptin‐induced VCAM‐1 Production in Mouse Chondrocytes

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging

In vivo contribution of promoter vitamin D response elements

A regulatory element in the 3′‐untranslated region of CEBPA is associated with myeloid/NK/T‐cell leukemia

In vivo contribution of Cyp24a1 promoter vitamin D response elements

CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification

Valproate and Short-Chain Fatty Acids Activate Transcription of the Human Vitamin D Receptor Gene through a Proximal GC-Rich DNA Region Containing Two Putative Sp1 Binding Sites

Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors

1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling Via Targeting Microrna-155-socs1 in Macrophages.

Repression of Transcription Mediated by Dual Elements in the CCAAT/enhancer Binding Protein Α Gene

Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression

An intronic enhancer of Cebpa regulates adipocyte differentiation and adipose tissue development via long‐range loop formation

Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand

The Adipocyte Differentiation Program: RepressiodDerepression of the C/EBPa Gene1

CEBPA mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition

Dominant-negative C/EBP Disrupts Mitotic Clonal Expansion and Differentiation of 3T3-L1 Preadipocytes